Browse current and past press releases from The Michael J. Fox Foundation.
-
Michael J. Fox Foundation for Parkinson’s Research Commits up to $2 Million to Visualize Alpha-Synuclein Protein in the Brain
-
Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
-
Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
-
New Michael J. Fox Foundation Initiative will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinson's Clinical Trials
-
Michael J. Fox Foundation Commits up to $2 Million to Improve Drug Delivery for Parkinson's Disease
-
Michael J. Fox Foundation Commits up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinson's Disease
-
Michael J. Fox Foundation Awards up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development